Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer

Abstract Background Detection of epidermal growth factor receptor (EGFR) mutations in exons 18–21 is recommended in all patients with advanced Non-small-cell lung carcinoma due to the demonstrated efficiency of the standard therapy with tyrosine kinase inhibitors in EGFR-mutated patients. Therefore,...

Full description

Bibliographic Details
Main Authors: Mercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, María José Hernández, Ángela María Blanco, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Bélgica Márquez-Lobo, Ana Alarcão, Enrique de Álava, Michele Biscuola
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
Non-small-cell lung carcinoma
EGFR
Mutations
Online Access:http://link.springer.com/article/10.1186/s12885-020-6697-7

Internet

http://link.springer.com/article/10.1186/s12885-020-6697-7

Similar Items